Blood Information Sheets
2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997
2007
- FDA Approves Product to Treat Common Bleeding Disorder - 4/30/2007
- FDA Licenses First Biologic Product to Prevent Hepatitis B Reinfection in Liver Transplant Patients - 4/6/2007
- FDA Approves First Biologic to Treat Rare Clotting Disorder - 3/30/2007
2006
- Testing Yourself for HIV-1, the Virus that Causes AIDS - 4/4/2006
- Heterogeneity of Alpha-1-Proteinase Inhibitor Products - 3/27/2006
- Varicella Zoster Immune Globulin (VZIG) - Anticipated Short Supply and Alternate Product Availability under an Investigational New Drug Application Expanded Access Protocol - 2/8/2006
2005
- Varicella Zoster Immune Globulin (VZIG) - Anticipated Short Supply - 9/20/2005 - Information update - 11/29/2005
- Safety of Albumin Administration in Critically Ill Patients - 5/16/2005
2004
- None issued in 2004
2003
- Update on Particulate Matter in Blood Bags - 10/31/2003
- Monkeypox Virus Infections and Blood and Plasma Donors - 6/13/2003
- FDA Current Thinking on Irradiating and/or Freezing Blood Components Collected and Stored in Anticoagulant/Preservative Solutions Not Specifically Approved for Such Use - 3/5/2003
- Frequently Asked Questions on FDA's Continuing Investigation of Particulate Matter in Blood - 2/27/2003
- Update on FDA's Continuing Investigation of Particulate Matter in Blood Shows Normal Blood Components and No Evidence for an Increase in Adverse Events - 2/27/2003
- Information Alert on Particulate Matter in Blood Bags - 2/7/2003
- FDA Recommends Temporary Additional Blood Inspection Measures as it Continues Investigation of Reports of White Particulate Matter in Some Units of Blood and Blood Components - 2/7/2003
2002
- FDA Interim Statement Regarding Immune Globulin Intravenous (IGIV) - 8/27/2002
- Important Recall Information Relating to Immune Globulin Intravenous (Human) - (Bayer Corp) - 3/20/2002, Updated 3/21/2002
- Recall of Immune Globulin Intravenous (Human) 10% Solvent/Detergent Treated, Gamimune N - (Bayer Corp) - 3/14/2002
- Recall of Immune Globulin Intravenous (Human) 10% Solvent/Detergent Treated, Gamimune N - (Bayer Corp) - 2/1/2002
2001
- Revised FDA Policy Statement on Urgent Collection, Shipment, and Use of Whole Blood and Blood Components Intended for Transfusion - 9/14/2001
- FDA Policy Statement on Urgent Collection, Shipment, and Use of Whole Blood and Blood Components Intended for Transfusion to Address Blood Supply Needs in the Current Disaster Situation - 9/11/2001
- Availability of Abbott / Murex Single Use Diagnostic System (SUDS) HIV-1 Test - 5/10/2001
2000
- Availability of Abbott / Murex Single Use Diagnostic System (SUDS) HIV-1 Test - 10/18/2000
- Murex SUDS HIV-1 (Rapid EIA) - MedWatch - 10/18/2000
1999
- Testing Yourself for HIV-1, the Virus that Causes AIDS - 5/6/1999, Updated 4/4/2006
1998
- Withdrawal of "Guidance for Industry: Supplemental Testing and the Notification of Consignees of Donor Test Results for Antibody to Hepatitis C Virus (Anti-HCV)" - 9/8/1998
- Guidance for Industry: Supplemental Testing and the Notification of Consignees of Donor Test Results for Antibody to Hepatitis C Virus (Anti-HCV) - 3/20/1998 - (PDF, 22 KB)
- Change to the Guidance Entitled "Revised Precautionary Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products" - 9/8/1998
1997
- Testing Yourself for HIV-1, the Virus that Causes AIDS - 5/9/1997, Updated 7/25/1997
- FDA/CDC Warn Against Blood Donations by Those Possibly Exposed to Tick-Borne Illnesses - 7/18/1997
- Recall of Blood Products In Six States Due to Risk of Tick-Borne Illnesses - 7/3/1997
- Statement on Intermountain Health Care, Inc - 4/26/1997